Skip to content

Clinical study of minimally invasive interventional therapy for relieving cancer visceral pain

Clinical study of minimally invasive interventional therapy for relieving cancer visceral pain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053494
Enrollment
Unknown
Registered
2021-11-22
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

case series:No

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with abdominal and pelvic cancer diagnosed by pathology; 2. The diagnosis of two or more pain specialists meets the diagnostic criteria for cancerous visceral pain; 3. VAS score (visual analog scale) before treatment >= 4 points; 4. The general condition is acceptable, and there are no relevant contraindications for minimally invasive interventional therapy.

Exclusion criteria

Exclusion criteria: 1. Severe heart and lung disease; 2. Severe liver and kidney insufficiency; 3. Past history of mental illness and opioid abuse; 4. There may be drug allergies related to the test; 5. Those who cannot obtain informed consent; 6. Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Daily consumption of opioids;

Countries

China

Contacts

Public ContactSong Li

Department of anesthesiology, West China Hospital of Sichuan University

song_li76@163.com+86 18980601501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026